Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Clinical trial NCT07479732 · RECRUITING

Trial details

NCT number: NCT07479732
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Osteosarcoma Metastatic

Start date: 2026-03-05
Primary completion: 2027-03-05
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.